Cargando…

Inhibition of the JAK/STAT Pathway With Baricitinib Reduces the Multiple Organ Dysfunction Caused by Hemorrhagic Shock in Rats

The aim of this study was to investigate (a) the effects of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway inhibitor (baricitinib) on the multiple organ dysfunction syndrome (MODS) in a rat model of hemorrhagic shock (HS) and (b) whether treatment with baricit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Nikita M., Collotta, Debora, Aimaretti, Eleonora, Ferreira Alves, Gustavo, Kröller, Sarah, Coldewey, Sina M., Collino, Massimo, Thiemermann, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249600/ https://www.ncbi.nlm.nih.gov/pubmed/35837955 http://dx.doi.org/10.1097/SLA.0000000000005571

Ejemplares similares

Inhibition of Bruton’s Tyrosine Kinase Activity Attenuates Hemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats
por: Patel, Nikita M., et al.
Publicado: (2023)

Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure
por: Verra, Chiara, et al.
Publicado: (2023)

Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
por: Collotta, Debora, et al.
Publicado: (2020)

Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice
por: O'Riordan, Caroline E., et al.
Publicado: (2019)

Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse
por: Coldewey, Sina M., et al.
Publicado: (2013)

Recent advances in JAK inhibitors for the treatment of metabolic syndrome
por: Collotta, Debora, et al.
Publicado: (2023)

Gender Dimorphism of the Cardiac Dysfunction in Murine Sepsis: Signalling Mechanisms and Age-Dependency
por: Chen, Jianmin, et al.
Publicado: (2014)

Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice
por: Alves, Gustavo Ferreira, et al.
Publicado: (2022)

‘Preconditioning’ with Low Dose Lipopolysaccharide Aggravates the Organ Injury / Dysfunction Caused by Hemorrhagic Shock in Rats
por: Sordi, Regina, et al.
Publicado: (2015)

Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock
por: Nandra, Kiran K., et al.
Publicado: (2013)

Inhibition of Macrophage Migration Inhibitory Factor Activity Attenuates Haemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats
por: Patel, Nikita M., et al.
Publicado: (2022)

X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure
por: O'Riordan, Caroline E., et al.
Publicado: (2020)

The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: Lessons for drug repurposing
por: Bertocchi, Ilaria, et al.
Publicado: (2020)

Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB
por: Al Zoubi, Sura, et al.
Publicado: (2018)

Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor
por: Khan, Areeg I., et al.
Publicado: (2013)

Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis
por: Coldewey, Sina M., et al.
Publicado: (2016)

ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis
por: Alves, Gustavo Ferreira, et al.
Publicado: (2022)

RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance
por: Chen, Jianmin, et al.
Publicado: (2020)

Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
por: Liu, Chang, et al.
Publicado: (2019)

Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells
por: Arnold, Rouven, et al.
Publicado: (2021)

Editorial: Community series in translational insights into mechanisms and therapy of organ dysfunction in sepsis and trauma, volume II
por: Relja, Borna, et al.
Publicado: (2023)

Bruton’s tyrosine kinase inhibition attenuates disease progression by reducing renal immune cell invasion in mice with hemolytic-uremic syndrome
por: Kröller, Sarah, et al.
Publicado: (2023)

Hemorrhagic Shock Sensitized the Diaphragm to Ventilator-Induced Dysfunction through the Activation of IL-6/JAK/STAT Signaling-Mediated Autophagy in Rats
por: Zhang, Li-Juan, et al.
Publicado: (2019)

Enhanced sphingosine-1-phosphate levels ameliorate murine septic cardiomyopathy
por: Coldewey, SM, et al.
Publicado: (2015)

A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice
por: Mohammad, Shireen, et al.
Publicado: (2021)

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
por: Sanchez, Gina A. Montealegre, et al.
Publicado: (2018)

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience
por: Taylor, Peter C., et al.
Publicado: (2023)

RG100204, A Novel Aquaporin-9 Inhibitor, Reduces Septic Cardiomyopathy and Multiple Organ Failure in Murine Sepsis
por: Mohammad, Shireen, et al.
Publicado: (2022)

Efficacy of Combination Therapy With The JAK Inhibitor Baricitinib In The Treatment of COVID-19
por: Thoms, Brendan Lawless, et al.
Publicado: (2021)

Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
por: Thoms, Brendan L., et al.
Publicado: (2022)

Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic–uremic syndrome: a pilot study
por: Neu, Charles, et al.
Publicado: (2023)

Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis
por: Deepak, H. B., et al.
Publicado: (2022)

Baricitinib alleviates lipopolysaccharide‑induced human periodontal ligament stem cell injury and promotes osteogenic differentiation by inhibiting JAK/STAT signaling
por: Yang, Ping, et al.
Publicado: (2022)

Scavenging Circulating Mitochondrial DNA as a Potential Therapeutic Option for Multiple Organ Dysfunction in Trauma Hemorrhage
por: Aswani, Andrew, et al.
Publicado: (2018)

Which is the Ideal JAK Inhibitor for Alopecia Areata – Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway
por: Sardana, Kabir, et al.
Publicado: (2023)

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
por: Jabbari, Ali, et al.
Publicado: (2015)

Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor
por: Scheinberg, Morton, et al.
Publicado: (2021)

Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery
por: Collotta, Debora, et al.
Publicado: (2023)

D-Tagatose Feeding Reduces the Risk of Sugar-Induced Exacerbation of Myocardial I/R Injury When Compared to Its Isomer Fructose
por: Durante, Mariaconcetta, et al.
Publicado: (2021)

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib
por: Kay, Jonathan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tvf63l81mt5mmj3efg2tijqbkv